Document Detail


The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential.
MedLine Citation:
PMID:  16445575     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sipatrigine (BW 619C89), a blocker of neuronal Na+ and Ca2+ channels that is structurally related to lamotrigine, has been shown to be neuroprotective in models of cortical ischaemia. Although associated with cardiovascular effects in animal models in vivo, there is no published information concerning the effects of sipatrigine on cardiac ion currents and action potentials (AP). The aim of the present study was to examine the effects of sipatrigine on the delayed rectifier currents (I(Kr) and I(Ks)), the inward rectifier current (I(K1)), the L-type Ca2+ current (I(Ca,L)) and the fast Na+ current (I(Na)), as well as on AP duration at 30% (APD30) and 90% (APD90) repolarization, in guinea-pig isolated ventricular myocytes. Each of the currents was inhibited by sipatrigine, demonstrating the drug to be a relatively broad-spectrum blocker of cation channels in the heart. However, sipatrigine was a comparatively more potent inhibitor of I(Kr) (IC50 = 0.85 micromol/L) and I(Ks) (IC50 = 0.92 micromol/L) than of I(K1) (IC50 = 5.3 micromol/L), I(Ca,L) (IC50 = 6.0 micromol/L) and I(Na) (IC50 = 25.5 micromol/L). Consistent with block of I(Kr), I(Ks) and I(K1), sipatrigine (1-30 micromol/L) produced a concentration-dependent prolongation of APD90. Although lower concentrations of sipatrigine (< or = 3 micromol/L) caused APD(30) prolongation, higher concentrations (> or = 10 micromol/L) shortened APD30, consistent with an involvement of I(Ca,L) blockade. The contrasting effects of sipatrigine on APD30 and APD90 at higher concentrations resulted in a marked concentration-dependent triangulation of the AP. 5. The results of the present study demonstrate that sipatrigine, at concentrations previously shown to be neuroprotective in vitro, modulates cardiac K+, Ca2+ and Na+ currents and repolarization of the cardiac ventricular action potential.
Authors:
Zhan Gao; James T Milnes; Stéphanie C M Choisy; Michael J Leach; Jules C Hancox; Andrew F James
Related Documents :
6173515 - Electrophysiological and antiarrhythmic properties of propafenon in isolated cardiac pr...
17578345 - I(ks) block by hmr 1556 lowers ventricular defibrillation threshold and reverses the re...
17212595 - L-type calcium current reactivation contributes to arrhythmogenesis associated with act...
7717565 - Myocyte contractile responsiveness after hypothermic, hyperkalemic cardioplegic arrest....
2822455 - Influence of trifluoperazine on acth- or angiotensin-stimulated mineralocorticoid and g...
2416975 - Augmentation of isoproterenol-stimulated tissue cyclic amp level by cholinergic agonist...
Publication Detail:
Type:  In Vitro; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical and experimental pharmacology & physiology     Volume:  32     ISSN:  0305-1870     ISO Abbreviation:  Clin. Exp. Pharmacol. Physiol.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2006-01-31     Completed Date:  2006-03-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0425076     Medline TA:  Clin Exp Pharmacol Physiol     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  1088-96     Citation Subset:  IM    
Affiliation:
Department of Physiology and Cardiovascular Research Laboratories, School of Medical Sciences, University of Bristol, Bristol, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Action Potentials / drug effects*
Animals
Calcium Channel Blockers / pharmacology
Cell Separation
Electrophysiology
Guinea Pigs
Heart / drug effects*
Heart Ventricles / drug effects
Ion Channels / drug effects*
Male
Myocytes, Cardiac / drug effects
Neuroprotective Agents / pharmacology*
Piperazines / pharmacology*
Potassium Channel Blockers / pharmacology
Pyrimidines / pharmacology*
Sodium Channel Blockers / pharmacology
Chemical
Reg. No./Substance:
0/Calcium Channel Blockers; 0/Ion Channels; 0/Neuroprotective Agents; 0/Piperazines; 0/Potassium Channel Blockers; 0/Pyrimidines; 0/Sodium Channel Blockers; 130800-90-7/sipatrigine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  BAY 41-2272, a potent activator of soluble guanylyl cyclase, stimulates calcium elevation and calciu...
Next Document:  Inhibitory effects of glucosamine on lipopolysaccharide-induced activation in microglial cells.